Slott, C.; Langer, S.W.; Møller, S.; Krogh, J.; Klose, M.; Hansen, C.P.; Kjaer, A.; Holmager, P.; Garbyal, R.S.; Knigge, U.;
et al. Outlook for 615 Small Intestinal Neuroendocrine Tumor Patients: Recurrence Risk after Surgery and Disease-Specific Survival in Advanced Disease. Cancers 2024, 16, 204.
https://doi.org/10.3390/cancers16010204
AMA Style
Slott C, Langer SW, Møller S, Krogh J, Klose M, Hansen CP, Kjaer A, Holmager P, Garbyal RS, Knigge U,
et al. Outlook for 615 Small Intestinal Neuroendocrine Tumor Patients: Recurrence Risk after Surgery and Disease-Specific Survival in Advanced Disease. Cancers. 2024; 16(1):204.
https://doi.org/10.3390/cancers16010204
Chicago/Turabian Style
Slott, Cecilie, Seppo W. Langer, Stine Møller, Jesper Krogh, Marianne Klose, Carsten Palnæs Hansen, Andreas Kjaer, Pernille Holmager, Rajendra Singh Garbyal, Ulrich Knigge,
and et al. 2024. "Outlook for 615 Small Intestinal Neuroendocrine Tumor Patients: Recurrence Risk after Surgery and Disease-Specific Survival in Advanced Disease" Cancers 16, no. 1: 204.
https://doi.org/10.3390/cancers16010204
APA Style
Slott, C., Langer, S. W., Møller, S., Krogh, J., Klose, M., Hansen, C. P., Kjaer, A., Holmager, P., Garbyal, R. S., Knigge, U., & Andreassen, M.
(2024). Outlook for 615 Small Intestinal Neuroendocrine Tumor Patients: Recurrence Risk after Surgery and Disease-Specific Survival in Advanced Disease. Cancers, 16(1), 204.
https://doi.org/10.3390/cancers16010204